Examination of Cognitive Function in Patients Treated With Subutex

BeerYaakov Mental Health Center

Status: Completed

Conditions: Opiate Addiction

Treatments: Other: Sexual, cognitive functional tests and measurement weight

Study type: Observational

Funder types: Other

Identifiers

NCT00687089

Subutex-214CTIL

Details and patient eligibility

About

People who addicted to Heroin and other opiates suffer from a disease with approved genetic basis. It causes to a behavioral response as searching and using those drugs even though they know it causes severe damages as physiological, familiar and legal affairs.

The popular treatment's goal is to "clean" the people from any drug. In a medical and pharmacological point of view there is no sense in this approach for all people. This point of view believes that Buprenorphine (Subutex) is a correct pharmacological treatment.

The hypothesis of this research is that people using Buprenorphine have difficulties in gaining weight, in sexual and cognitive function (according to subjects' reports)

Full description

People who addicted to Heroin and other opiates suffer from a disease with approved genetic basis. It causes to a behavioral response as searching and using those drugs even though they know it causes severe damages as physiological, familiar and legal affairs.

The popular treatment's goal is to "clean" the people from any drug. In a medical and pharmacological point of view there is no sense in this approach for all people. This point of view believes that Buprenorphine (Subutex) is a correct pharmacological treatment.

The hypothesis of this research is that people using Buprenorphine have difficulties in gaining weight, in sexual and cognitive function (according to subjects' reports) We examine people who stopped opiates and began Buprenorphine. Every participant in the study will have two visits: the first one before receiving Buprenorphine and the second one after 3 months of receiving Buprenorphine.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• People who suffer from addiction problems (opiates)
• People who willing to to start Buprenorphine treatment
• People who willing to cooperate with study tests and questionnaires
• People aged 18 to 70

Exclusion criteria

• People who suffer from any neurocognitive problems
• People who suffer from mental illnesses
• People who are having legal guardian

Trial design

60 participants in 1 patient group

Subutex group

Description:

People who used opiates and willing to start with subutex treatment

Treatment:

Other: Sexual, cognitive functional tests and measurement weight